You are here

  • Home
  • Archive
  • Volume 95, Issue Suppl 1
  • Admission mid-regional pro-adrenomedullin is a more potent predictor of early adverse events than Grace clinical risk score in patients with non-ST elevation acute coronary syndromes

Article info

Article menu
Download PDFPDF
BCS abstracts 51-100
Admission mid-regional pro-adrenomedullin is a more potent predictor of early adverse events than Grace clinical risk score in patients with non-ST elevation acute coronary syndromes

Authors

Citation

Dhillon O, Khan S, Ponnambath S, et al
Admission mid-regional pro-adrenomedullin is a more potent predictor of early adverse events than Grace clinical risk score in patients with non-ST elevation acute coronary syndromes
Heart 2009;95:77.

Publication history

  • First published September 22, 2015.
Online issue publication 
March 15, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

2009 BMJ Publishing Group and British Cardiovascular Society